Maynard Um
-
-
-
-
-
-
-
Alvotech issues 12.5 million shares to subsidiary for $65 million
-
-
-
-
-
-
-
Alvotech and Teva reach settlement for Eylea biosimilar launch in Q4 2026
-
-
-
-
-
-
-
Deutsche Bank Downgrades Alvotech SA (ALVO) to Hold
-
-
-
-
-
-
-
Alvotech receives Japan approval for three biosimilars
-
-
-
-
-
-
-
Alvotech's (ALVO) Private Placement Completed with Delivery of SDRs and Shares to Investors
-
-
-
-
-
-
-
Alvotech (ALVO) and Teva (TEVA) Announce SELARSDI Injection Now Available in the U.S.
-
-
-
-
-
-
-
Citi Reiterates Neutral Rating on Alvotech SA (ALVO)
-
424,907 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

